StonvexLoading…
StonvexCore line items from LNT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.36B | $3.98B | $4.03B | $4.21B |
Operating Income | $1.02B | $886.00M | $943.00M | $928.00M |
Net Income | $810.00M | $690.00M | $703.00M | $686.00M |
EPS (Diluted) | $3.14 | $2.69 | $2.78 | $2.73 |
Total Assets | $24.99B | $22.71B | $21.24B | $20.16B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $556.00M | $81.00M | $62.00M | $20.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | $-998.00M |
Shares Outstanding | 257.14M | 256.69M | 256.10M | 251.13M |